Altai Protocol Library New Reference: Tafasitamab with Rituximab/Lenalidomide for Rel/Ref Follicular Lymphoma U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Drug: Savolitinib with Osimertinib for EGFR-Mutated, MET-Amplified NSCLC U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Indication: Ribociclib + Letrozole for Low-Grade Serous Ovarian Cancer U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Reference: Pirtobrutinib vs. Ibrutinib in CLL U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Indication: Pirtobrutinib for Untreated CLL without del(17p) U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Protocol: Neoadjuvant Low-dose Pembrolizumab for Triple-Negative Breast Cancer U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Reference: Adjuvant Nivolumab for Muscle-Invasive Bladder Cancer U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Protocol: Adjuvant Nivolumab with CISplatin Concurrently with Radiotherapy for Head and Neck Cancer U. Darda Bayraktar, MD 2026-01-21
Altai Protocol Library New Reference: FOLFOXIRI with Panitumumab for 1st Line Metastatic RAS/RAF WT Colorectal Cancer U. Darda Bayraktar, MD 2026-01-21
